F2G and Shionogi’s olorofim met its goals in a late-stage study, setting the stage for an FDA filing this year ...

A ruthenium-based reaction exploits the stronger carbon-deuterium bond to enrich one mirror-image form from a racemic mixture ...

The program, being piloted in China, aims to celebrate professional achievements, scientific contributions, and social impact ...

To refine rare earths, Alta’s engineers attach the proteins to chromatography resin that is used to separate the elements.

Finally, we should be worried about how these trial markets could impact public perception of the drug development and ...

Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...

Ira Remsen, founding faculty member at Johns Hopkins University, established the US’s first graduate program in chemistry ...

Over $1 billion sat unused in US National Science Foundation (NSF) accounts as fiscal 2026 came to a close Oct. 1. A White ...

Researchers at the Swiss Federal Institute of Technology (ETH), Zurich, have designed an implant that converts excess blood ...

The surface of an Andes virus is covered in protein spikes with which it attaches to human cells. Researchers have now mapped ...

Estuary Biotherapeutics, which is developing gene therapies to treat kidney disease, has launched with $103 million in ...

Estuary is now plotting human trials that will begin in 2027 and 2028. The first will test EST-201, a Pkd2 gene therapy for ...